Articles

  • Jan 24, 2025 | maritime-executive.com | Cameron Mitchell

    The maritime industry is notoriously susceptible to the virus of corruption. However, after spending a year as member of the Maritime Anti Corruption Network (MACN), I believe we are starting to see signs that concerted action is beginning to pay off. It is now becoming better understood that the layers of bureaucracy that surround a ship in port - up to seven industry organizations and seven government bodies - can no longer be exploited with impunity. The MACN can take large credit for this.

  • Nov 28, 2024 | biorxiv.org | Emma Murray |Leighton Lee |Cameron Mitchell |Gilian M. Hodge

    AbstractThe organization of the cell′s cytoskeletal filaments is coordinated through a complex symphony of signaling cascades originating from internal and external cues. Two major actin regulatory pathways are signal transduction through Rho family GTPases and growth and proliferation signaling through the Hippo pathway. These two pathways act to define the actin cytoskeleton, controlling foundational cellular attributes such as morphology and polarity.

  • Oct 25, 2024 | hudl.com | Cameron Mitchell

    Oops! It looks like AdBlock or a similar tool has prevented this page from loading. Please disable the plugin for all Hudl.com pages and refresh your browser. 7 views | 1:58 | Oct 26, 2024

  • Sep 24, 2024 | uspostnews.com | Cameron Mitchell

    While Nikola Corp has underperformed by -2.09%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NKLA fell by -87.52%, with highs and lows ranging from $51.00 to $4.78, whereas the simple moving average fell by -71.77% in the last 200 days. On May 16, 2024, Bryan Garnier started tracking Nikola Corp (NASDAQ: NKLA) recommending Buy.

  • Sep 9, 2024 | uspostnews.com | Cameron Mitchell

    While Autolus Therapeutics plc ADR has overperformed by 2.12%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AUTL rose by 31.09%, with highs and lows ranging from $7.45 to $2.01, whereas the simple moving average fell by -16.86% in the last 200 days. On November 09, 2023, Deutsche Bank started tracking Autolus Therapeutics plc ADR (NASDAQ: AUTL) recommending Buy.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →